ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis

Liang, Zongyu*; Li, Zhu; Yang, Qingshui; Feng, Jiahao; Xiang, Deyu; Lyu, Haina; Mai, Guangzhi; Wang, Wanchuan*6
Frontiers in Oncology2022-10-11DOI: 10.3389/fonc.2022.1024345
1被引9阅读
引用收藏
分享

摘要

Background: Controversy persists about neoadjuvant chemotherapy (NAC) within the field of locally advanced colon cancer (LACC). The purpose of this study was to assess the existing and latest literature with high quality to determine the role of NAC in various aspects. Methods: A comprehensive literature search of the PubMed, Embase, Web of Science, and the Cochrane Library databases was conducted from inception to April 2022. Review Manager 5.3 was applied for meta-analyses with a random-effects model whenever possible. Results: Overall, 8 studies were included in this systematic review and meta-analysis, comprising 4 randomized controlled trials (RCTs) and 4 retrospective studies involving 40,136 participants. The 3-year overall survival (OS) (HR: 0.90, 95% CI: 0.66-1.23, P = 0.51) and 5-year OS (HR: 0.89, 95% CI: 0.53-1.03, P = 0.53) were comparable between two groups. Mortality in 30 days was found less frequent in the NAC group (OR: 0.43, 95% CI: 0.20-0.91, P = 0.03), whereas no significant differences were detected concerning other perioperative complications, R0 resection, or adverse events. In terms of subgroup analyses for RCTs, less anastomotic leak (OR: 0.51, 95% CI: 0.31-0.86, P = 0.01) and higher R0 resection rate (OR: 2.35, 95% CI: 1.04-5.32, P = 0.04) were observed in the NAC group. Conclusions: NAC is safe and feasible for patients with LACC, but no significant survival benefit could be demonstrated. The application of NAC still needs to be prudent until significant evidence supporting the oncological outcomes is presented.Systematic review registrationhttps://www.crd.york.ac.uk/prospero, identifier (CRD42022333306).

学科与关键词

关键词
neoadjuvant chemotherapylocally advanced colon canceroverall survivalR0 resectionperioperative complication
相关
加载中…
  • Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
    Xiang, Meijuan; Liang, Zongyu; Gao, Yuan; Feng, Xingyu*; Yao, Xueqing*Frontiers in Surgery, 2022, 9: 1022025.被引 1
  • Laparoscopic Versus Open Surgery Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: a Systematic Review and Meta-analysis
    Chen Hao; Zhao Liying; An Shengli; Wu Jiaming; Zou Zhenhong; Liu Hao*; Li GuoxinJournal of Gastrointestinal Surgery, 2014, 18(3): 617-626.被引 5
  • Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
    Pan, Long; Fang, Jing; Tong, Chenhao; Chen, Mingyu; Zhang, Bin; Juengpanich, Sarun; Wang, Yifan*; Cai, Xiujun*WORLD JOURNAL OF SURGICAL ONCOLOGY, BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 1, 2020-12-31.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-10-11
卷期
第 12 卷
页码
1024345
DOI
10.3389/fonc.2022.1024345
期刊等级
3区
成果收录
SCIE

作者

  • L

    Liang, Zongyu (通讯) (第一作者)

    2 · 6

  • L

    Li, Zhu

    2 · 6

查看全部 8 位作者收起作者
  • Y

    Yang, Qingshui

    2 · 6

  • F

    Feng, Jiahao

    2 · 6

  • X

    Xiang, Deyu

    2 · 6

  • L

    Lyu, Haina

    2 · 6

  • M

    Mai, Guangzhi

    2 · 6

  • W

    Wang, Wanchuan (通讯)

    2 · 6

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417